Pharmacia Azulfidine EN-tabs
This article was originally published in Pharmaceutical Approvals Monthly
Sulfasalazine delayed-release tablets approved Aug. 18 for treatment of polyarticular course juvenile rheumatoid arthritis in patients aged six to 16 who have five or more diseased joints and who have responded inadequately to salicylates or other nonsteroidal anti-inflammatory drugs. The sNDA was supported by a 24-week tria
You may also be interested in...
Hologic made its third big acquisition of 2021 and Agilent agreed to pay up to $695m for Resolution Bioscience to extend its precision oncology capabilities.
Broader than initially reported, Merck & Co.’s agreement with BARDA extends beyond J&J’s recently authorized vaccine to other COVID-19 vaccines and therapeutics as needed.
White House, Democrat majority in Congress and likely next FTC chair support the agency wielding the authority, says advertising law attorney Holly Melton. Supreme Court, though, likely will rule in pending cases that a strict reading of an FTC regulation doesn’t grant monetary penalty authority.